Elise M. Pelletier, MS

Articles by Elise M. Pelletier, MS

Patient Out-of-Pocket Payments for Oral Oncolytics: Results From a 2009 US Claims Data Analysis

ByMartin L. Raborn, MPharm, MBA,Elise M. Pelletier, MS,Daniel B. Smith, MA,Carolina M. Reyes, PhD

May 10th 2012

Out-of-pocket payments differ widely among oral oncolytic options. As cost for therapy becomes a greater part of treatment decisions, an understanding of patient out-of-pocket cost will be critical in informing choices.

Pharmacotherapy Adherence and Costs Versus Nonpharmacologic Management in Overactive Bladder

ByElise M. Pelletier, MS,Vasudha Vats, MPH,J. Quentin Clemens, MD, MSCI

March 24th 2009

Elise M. Pelletier, MS

Articles by Elise M. Pelletier, MS

Patient Out-of-Pocket Payments for Oral Oncolytics: Results From a 2009 US Claims Data Analysis

Pharmacotherapy Adherence and Costs Versus Nonpharmacologic Management in Overactive Bladder

Latest Updated Articles

Trending on AJMC

Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology

FDA Approves Another OTC Naloxone Nasal Spray for Opioid Overdose

5 Questions Dermatology Patients May Have About Newly-Approved Bemotrizinol

Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies

Venetoclax-Obinutuzumab Tops Acalabrutinib in First-Line CLL